Queen鈥檚 Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds" on March 4, 2025 to Rebecca Grange, John Allingham, Andrew Craig, P. Andrew Evans, and Madhu Aeluri. The patent relates to a class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer.